RNA Isoforms as Broad Targets for Cancer Immunotherapy
G Li, N Salomonis - DNA and Cell Biology, 2024 - liebertpub.com
While immunotherapy is typically reserved for cancer patients with a high mutational burden,
neoantigens produced from post-transcriptional regulation provide a possible untapped …
neoantigens produced from post-transcriptional regulation provide a possible untapped …
RNA Isoforms as Broad Targets for Cancer Immunotherapy.
G Li, N Salomonis - DNA and Cell Biology, 2024 - europepmc.org
While immunotherapy is typically reserved for cancer patients with a high mutational burden,
neoantigens produced from post-transcriptional regulation provide a possible untapped …
neoantigens produced from post-transcriptional regulation provide a possible untapped …
RNA Isoforms as Broad Targets for Cancer Immunotherapy
G Li, N Salomonis - DNA and cell biology - pubmed.ncbi.nlm.nih.gov
While immunotherapy is typically reserved for cancer patients with a high mutational burden,
neoantigens produced from post-transcriptional regulation provide a possible untapped …
neoantigens produced from post-transcriptional regulation provide a possible untapped …